Bank of America Securities Sticks to Its Buy Rating for Acumen Pharmaceuticals (ABOS)
In a report released today, Jason Zemansky from Bank of America Securities reiterated a Buy rating on Acumen Pharmaceuticals (ABOS – Research ...